Maruti Uppalapati

Maruti Uppalapati

University of Saskatchewan

H-index: 17

North America-Canada

About Maruti Uppalapati

Maruti Uppalapati, With an exceptional h-index of 17 and a recent h-index of 12 (since 2020), a distinguished researcher at University of Saskatchewan, specializes in the field of Protein engineering.

His recent articles reflect a diverse array of research interests and contributions to the field:

225Ac/89Zr labeled anti nectin 4 radioimmunoconjugates as theranostics against nectin 4 positive triple negative breast cancer

Antibodies to igf2r and methods

[225Ac] Ac/[89Zr] Zr-labeled N4MU01 radioimmunoconjugates as theranostics against nectin-4 positive triple negative breast cancer

Efficacy of [67Cu] Cu-EB-TATE Theranostic Against Somatostatin Receptor Subtype-2–Positive Neuroendocrine Tumors

Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma

Comparative Molecular Characterization and Pharmacokinetics of IgG1-Fc and Engineered Fc Human Antibody Variants to Insulin-like Growth Factor 2 Receptor (IGF2R)

Image-Based Dosimetry in Dogs and Cross-Reactivity with Human Tissues of IGF2R-Targeting Human Antibody

Engineering of bidirectional, cyanobacteriochrome-based light-inducible dimers (BICYCL) s

Maruti Uppalapati Information

University

Position

___

Citations(all)

1008

Citations(since 2020)

458

Cited By

788

hIndex(all)

17

hIndex(since 2020)

12

i10Index(all)

22

i10Index(since 2020)

15

Email

University Profile Page

University of Saskatchewan

Google Scholar

View Google Scholar Profile

Maruti Uppalapati Skills & Research Interests

Protein engineering

Top articles of Maruti Uppalapati

Title

Journal

Author(s)

Publication Date

225Ac/89Zr labeled anti nectin 4 radioimmunoconjugates as theranostics against nectin 4 positive triple negative breast cancer

Cancer Research

Hanan Babeker

Fabrice Njotu

Jessica Ketchmen

Florence Tikum

Alireza Doroudi

...

2024/3/22

Antibodies to igf2r and methods

2024/4/18

[225Ac] Ac/[89Zr] Zr-labeled N4MU01 radioimmunoconjugates as theranostics against nectin-4 positive triple negative breast cancer

bioRxiv

Hanan Babeker

Fabrice Ngoh Njotu

Jessica Pougoue Ketchemen

Anjong Florence Tikum

Alireza Doroudi

...

2024

Efficacy of [67Cu] Cu-EB-TATE Theranostic Against Somatostatin Receptor Subtype-2–Positive Neuroendocrine Tumors

Journal of Nuclear Medicine

Fabrice Ngoh Njotu

Jessica Pougoue Ketchemen

Anjong Florence Tikum

Hanan Babeker

Brian D Gray

...

2024/4/1

Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma

Nuclear Medicine and Biology

Sabeena Giri

Kevin JH Allen

Chandra Bose Prabaharan

Jonathan Bonet Ramirez

Luciano Fiore

...

2024/5/1

Comparative Molecular Characterization and Pharmacokinetics of IgG1-Fc and Engineered Fc Human Antibody Variants to Insulin-like Growth Factor 2 Receptor (IGF2R)

Molecules

Chandra B Prabaharan

Sabeena Giri

Kevin JH Allen

Katrina EM Bato

Therese R Mercado

...

2023/8/3

Image-Based Dosimetry in Dogs and Cross-Reactivity with Human Tissues of IGF2R-Targeting Human Antibody

Pharmaceuticals

Kevin JH Allen

Ohyun Kwon

Matthew R Hutcheson

Joseph J Grudzinski

Stuart M Cain

...

2023/7/8

Engineering of bidirectional, cyanobacteriochrome-based light-inducible dimers (BICYCL) s

Nature Methods

Jaewan Jang

Kun Tang

Jeffrey Youn

Sherin McDonald

Hannes M Beyer

...

2023/3

Abstract A150: Effects of radioimmunotherapy on human and canine osteosarcoma microenvironment

NaN

Sabeena Giri

Kevin JH Allen

Maruti Uppalapati

Ekaterina Dadachova

2023

Development and initial evaluation of a fully human anti-nectin-4 antibody as theranostic probes for nectin-4 positive triple negative breast cancers

Hanan Babeker

Jessica Pougoue Ketchemen

Arun Sudarsun

Samitha Andrahendi

Florence Tikum

...

2022/6/1

Engineering of a fully human anti-MUC-16 antibody and evaluation as a PET imaging agent

Pharmaceutics

Hanan Babeker

Jessica Pougoue Ketchemen

Arunkumar Annan Sudarsan

Samitha Andrahennadi

Anjong Florence Tikum

...

2022/12/16

D-peptidic compounds for vegf

2021/3/4

A Non-immunogenic Bivalent d-Protein Potently Inhibits Retinal Vascularization and Tumor Growth

ACS Chemical Biology

Paul S Marinec

Kyle E Landgraf

Maruti Uppalapati

Gang Chen

Daniel Xie

...

2021/2/23

Radioimmunotherapy targeting IGF2R on canine-patient-derived osteosarcoma tumors in mice and radiation dosimetry in canine and pediatric models

Pharmaceuticals

Jaline Broqueza

Chandra B Prabaharan

Kevin JH Allen

Rubin Jiao

Darrell R Fisher

...

2021/12/22

Generation of Protein Inhibitors for Validation of Cancer Drug Targets Identified in Functional Genomic Screens

Mapping Genetic Interactions

Sherin McDonald

Arunkumar Annan Sudarsan

Hanan Babeker

Kiranmayee Budharaju

Maruti Uppalapati

2021

Structure‐based design of a photoswitchable affibody scaffold

Protein Science

Ryan M Woloschuk

P Maximilian M Reed

Anna SI Jaikaran

Karl Z Demmans

Jeffrey Youn

...

2021/12

The EphB6 receptor: kinase-dead but very much alive

Timothy G Strozen

Jessica C Sharpe

Evelyn D Harris

Maruti Uppalapati

Behzad M Toosi

2021/7/30

Novel human antibodies to insulin growth factor 2 receptor (IGF2R) for radioimmunoimaging and therapy of canine and human osteosarcoma

Cancers

Jaline Broqueza

Chandra B Prabaharan

Samitha Andrahennadi

Kevin JH Allen

Ryan Dickinson

...

2021/5/4

Using comparative oncology approach to develop radioimmunotherapy for osteosarcoma

Jaline Broqueza

Samitha Andrahennadi

Kevin Allen

Ryan Dickinson

Valerie MacDonald-Dickinson

...

2020/5/1

Yeast two-hybrid screening of photoswitchable protein–protein interaction libraries

Journal of molecular biology

Ryan M Woloschuk

P Maximilian M Reed

Sherin McDonald

Maruti Uppalapati

G Andrew Woolley

2020/5/1

See List of Professors in Maruti Uppalapati University(University of Saskatchewan)